“Our findings provide insight into severe bacterial infectious diseases, as well as some forms of cancer, in which the attachment of fat molecules to proteins is an essential feature of the disease process,” said Dr. Neal Alto, assistant professor of microbiology and senior author of the study in today’s print edition of Nature. The study’s first author is Nikolay Burnaevskiy, a graduate student in microbiology.
The research group discovered a scissor-like enzyme that specifically cuts off functionally-essential fatty acids from proteins. “The one we studied in particular – a 14-carbon saturated fatty acid called myristic acid– has received a lot of attention due to its crucial role in the transformation of normal cells to cancer cells and for promoting cancer cell growth,” Dr. Alto said.
Because of the fat’s importance in human disease, researchers have tried for years to identify effective methods to remove them from proteins. “To our amazement, bacteria have invented the precise tool for the job,” Dr Alto said.
The bacteria used in this study, Shigella flexneri, are able to cross the intestinal wall and infect immune cells. Other intestinal bacteria, such as E. coli, are unable to do this. Once Shigella encounters immune system cells, including white blood cells such as macrophages, the bacteria use a needle-like complex to inject the cells with about 20 bacterial toxins.
The UTSW researchers conducted a series of experiments to characterize one of those toxins, called IpaJ, chosen in part because so little was known about the protein. They not only discovered IpaJ’s fat-cutting ability, but also determined how the protein disables the immune system’s communication infrastructure, which Dr. Alto compared to knocking out a bridge needed to deliver a package.
“Normally, a macrophage will engulf an invading bacteria and send out cytokines, proteins that act as cellular alert signals, which in turn recruit more immune cells to the site of infection,” Dr. Alto said. “When the macrophages engulf Shigella, however, the bacteria use IpaJ to cut fatty acids from proteins, which need those fats attached in order to sound the alarm. Doing so buys more time for the bacteria to grow and survive.
“It’s very interesting from a disease process point of view, but it’s also important because we now have a potential drug target,” said Dr. Alto. The next step, he said, will be to identify small molecule inhibitors that are specific to this fat-snipping protease and that might be developed into drugs.
The study in Nature received support from the National Institutes of Health, the Welch Foundation, and the Burroughs Wellcome Fund.
Other researchers from UTSW involved are Dr. Steven Patrie, assistant professor of pathology; former pediatrics fellow Dr. Thomas Fox, now an assistant professor of clinical pediatrics at Indiana University; Daniel Plymire, a graduate student of pathology in the molecular biophysics program; and graduate students Andrey Selyunin and Bethany Weigele, both in the molecular microbiology program. Researchers from the University of Cincinnati also participated in the investigation.About UT Southwestern Medical Center
Deborah Wormser | Newswise
What the world's tiniest 'monster truck' reveals
23.08.2017 | American Chemical Society
23.08.2017 | Empa - Eidgenössische Materialprüfungs- und Forschungsanstalt
16.08.2017 | Event News
04.08.2017 | Event News
26.07.2017 | Event News
23.08.2017 | Life Sciences
23.08.2017 | Life Sciences
23.08.2017 | Physics and Astronomy